Bronchial artery embolisation in management of hemoptysis--A retrospective analysis in a tertiary university hospital
| Autor: | R. Gomes, P. Morgado, J. Paquete, Hans Dabó, Anabela Marinho, M. Madureira |
|---|---|
| Rok vydání: | 2015 |
| Předmět: |
Male
medicine.medical_specialty Hemoptysis Tuberculosis Bronchial Arteries Cystic fibrosis 030218 nuclear medicine & medical imaging Hospitals University Tertiary Care Centers 03 medical and health sciences 0302 clinical medicine medicine.artery Internal medicine Materials Chemistry medicine Humans Bronchial artery embolisation Retrospective Studies lcsh:RC705-779 Bronchiectasis business.industry Retrospective cohort study lcsh:Diseases of the respiratory system Middle Aged medicine.disease Embolization Therapeutic Surgery Pulmonary embolism Pulmonology 030228 respiratory system Etiology Female Radiology Bronchial artery business Pulmonary Embolism |
| Zdroj: | Revista Portuguesa de Pneumologia (English Edition), Vol 22, Iss 1, Pp 34-38 (2016) |
| ISSN: | 2173-5115 |
| Popis: | Background: Bronchial artery embolisation (BAE) becomes a mainstay in the treatment of hemoptysis. Objective: To characterise patients with hemoptysis undergoing bronchial artery angiography (BAA) for embolisation, evaluating outcomes. Methods: We retrospectively evaluated patients with acute severe or chronic recurrent hemoptysis admitted to the Pulmonology department and submitted to BAA for purpose of embolisation. Results: A total of 88 patients were submitted to BAA, 47 (53.4%) were male, with a mean age of 61.4 ± 15.8 years. In 64 (72.7%) patients, hemoptysis presented as chronic recurrent episodes. Hemoptysis was considered severe in 40 (45.5%) patients. Bronchiectasis (other than cystic fibrosis) (n = 35; 38.0%) and tuberculosis sequelae (n = 31; 35.2) were the major aetiology for hemoptysis. The main angiographic abnormality was hypertrophy and tortuosity (n = 68; 77.3%). BAE was performed in 67 (76.1%) of the 88 patients submitted to BAA. Immediate success was achieved in 66 (98.5%) patients. Recurrence of hemoptysis occurred in 25 (37.3%) patients, and was related to presence of shunting (p = 0.049). The procedure-related complications were self-limited. Conclusion: Our results suggest that BAE is a safe and effective treatment for acute severe and chronic recurrent hemoptysis, supporting the current literature. Besides this, bleeding recurrence was relatively high, and correlated with presence of systemic pulmonary shunting. Keywords: Hemoptysis, Bronchiectasis, Bronchial artery embolisation |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|